186 related articles for article (PubMed ID: 22492974)
1. Simvastatin decreases invasiveness of human endometrial stromal cells.
Sokalska A; Cress A; Bruner-Tran KL; Osteen KG; Taylor HS; Ortega I; Duleba AJ
Biol Reprod; 2012 Jul; 87(1):2, 1-6. PubMed ID: 22492974
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin reduces steroidogenesis by inhibiting Cyp17a1 gene expression in rat ovarian theca-interstitial cells.
Ortega I; Cress AB; Wong DH; Villanueva JA; Sokalska A; Moeller BC; Stanley SD; Duleba AJ
Biol Reprod; 2012 Jan; 86(1):1-9. PubMed ID: 21918126
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin induces apoptosis and alters cytoskeleton in endometrial stromal cells.
Sokalska A; Wong DH; Cress A; Piotrowski PC; Rzepczynska I; Villanueva J; Duleba AJ
J Clin Endocrinol Metab; 2010 Jul; 95(7):3453-9. PubMed ID: 20427495
[TBL] [Abstract][Full Text] [Related]
4. Lipophilic statins inhibit growth and reduce invasiveness of human endometrial stromal cells.
Sokalska A; Hawkins AB; Yamaguchi T; Duleba AJ
J Assist Reprod Genet; 2019 Mar; 36(3):535-541. PubMed ID: 30554393
[TBL] [Abstract][Full Text] [Related]
5. Statins inhibit blastocyst formation by preventing geranylgeranylation.
Alarcon VB; Marikawa Y
Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
[TBL] [Abstract][Full Text] [Related]
6. Role of isoprenylation in simvastatin-induced inhibition of ovarian theca-interstitial growth in the rat.
Rzepczynska IJ; Piotrowski PC; Wong DH; Cress AB; Villanueva J; Duleba AJ
Biol Reprod; 2009 Nov; 81(5):850-5. PubMed ID: 19571257
[TBL] [Abstract][Full Text] [Related]
7. Effects of simvastatin on retinoic acid system in primary human endometrial stromal cells and in a chimeric model of human endometriosis.
Sokalska A; Anderson M; Villanueva J; Ortega I; Bruner-Tran KL; Osteen KG; Duleba AJ
J Clin Endocrinol Metab; 2013 Mar; 98(3):E463-71. PubMed ID: 23337719
[TBL] [Abstract][Full Text] [Related]
8. Expression of Matrix Metalloproteinases and Their Inhibitors in Endometrium: High Levels in Endometriotic Lesions.
Luddi A; Marrocco C; Governini L; Semplici B; Pavone V; Luisi S; Petraglia F; Piomboni P
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325785
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells.
Villanueva JA; Sokalska A; Cress AB; Ortega I; Bruner-Tran KL; Osteen KG; Duleba AJ
J Clin Endocrinol Metab; 2013 Mar; 98(3):E455-62. PubMed ID: 23386644
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells.
Wong DH; Villanueva JA; Cress AB; Sokalska A; Ortega I; Duleba AJ
Fertil Steril; 2011 Nov; 96(5):1252-8. PubMed ID: 21907337
[TBL] [Abstract][Full Text] [Related]
12. Mononuclear phagocyte morphological response to chemoattractants is dependent on geranylgeranyl pyrophosphate.
Krauklis SA; Hussain J; Murphy KM; Dray EL; Ousley CG; Justyna K; Distefano MD; Steelman AJ; McKim DB
Am J Physiol Endocrinol Metab; 2024 Jul; 327(1):E55-E68. PubMed ID: 38717364
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin suppresses leptin expression in 3T3-L1 adipocytes via activation of the cyclic AMP-PKA pathway induced by inhibition of protein prenylation.
Maeda T; Horiuchi N
J Biochem; 2009 Jun; 145(6):771-81. PubMed ID: 19254925
[TBL] [Abstract][Full Text] [Related]
14. Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation.
Weivoda MM; Hohl RJ
Endocrinology; 2011 Aug; 152(8):3113-22. PubMed ID: 21586555
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin-mediated enhancement of long-term potentiation is driven by farnesyl-pyrophosphate depletion and inhibition of farnesylation.
Mans RA; McMahon LL; Li L
Neuroscience; 2012 Jan; 202():1-9. PubMed ID: 22192838
[TBL] [Abstract][Full Text] [Related]
16. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L
Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin exerts anticancer effects in osteosarcoma cell lines via geranylgeranylation and c-Jun activation.
Kany S; Woschek M; Kneip N; Sturm R; Kalbitz M; Hanschen M; Relja B
Int J Oncol; 2018 Apr; 52(4):1285-1294. PubMed ID: 29532878
[TBL] [Abstract][Full Text] [Related]
18. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.
Hu WL; Qiao SB; Li JJ
Cytokine; 2007 Dec; 40(3):201-6. PubMed ID: 18023360
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway.
Woschek M; Kneip N; Jurida K; Marzi I; Relja B
Nutr Cancer; 2016; 68(3):420-7. PubMed ID: 27042994
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
